Eliem Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eliem Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Eliem Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $21K, a 94.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $21K -$351K -94.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $111K -$551K -83.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $199K -$272K -57.7% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $286K -$299K -51.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $372K -$325K -46.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $662K -$145K -18% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $471K +$471K Dec 31, 2022 10-K 2024-03-28
Q3 2022 $585K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $697K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $807K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.